ARCHIVES

FDA Approves Inlyta Pill For Renal Cell Carcinoma

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

CDC Warns Burton Patients Of Risk Of HTLV-3 Infection

August 16, 1985

FDA Invites Ad Hoc Consumer Reps To ODAC Meetings

February 17, 1995

Advocacy Group Tells Chicago Tribune That AIDS, Not Gallo, Is Issue

September 21, 1990

NIH To Site Visit Animal Facilities

March 18, 1983

NCI-Approved Group, Center Clinical Trials Listed

May 25, 2007

FDA Backs Down, Releases INDs, But Revives Controversy Over Clinical Testing Guidelines

March 12, 1976